Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 31 October

Sophia Mavridis
October 31, 2022

Weekly Wrap 28 October

Grady Wulff
October 28, 2022

Morning Bell 28 October

Sophia Mavridis
October 28, 2022

Closing Bell 27 October

Grady Wulff
October 27, 2022

Morning Bell 27 October

Grady Wulff
October 27, 2022

Closing Bell 26 October

Sophia Mavridis
October 26, 2022

Morning Bell 26 October

Sophia Mavridis
October 26, 2022

Closing Bell 25 October

Sophia Mavridis
October 25, 2022

Morning Bell 25 October

Sophia Mavridis
October 25, 2022

Closing Bell 24 October

Grady Wulff
October 24, 2022

Morning Bell 24 October

Grady Wulff
October 24, 2022

Weekly Wrap 21 October

Grady Wulff
October 21, 2022